Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial.
De Icco R, Vaghi G, Allena M, Ghiotto N, Guaschino E, Martinelli D, Ahmad L, Corrado M, Bighiani F, Tanganelli F, Bottiroli S, Cammarota F, Sances G, Tassorelli C.
De Icco R, et al. Among authors: martinelli d.
J Headache Pain. 2022 Sep 17;23(1):123. doi: 10.1186/s10194-022-01480-2.
J Headache Pain. 2022.
PMID: 36115947
Free PMC article.
Clinical Trial.